I-Mab Biopharma
IMAB
$11.81
Share price
1.11%
Change (1 day)
-84.15%
Change (1 year)
Categories
Market capitalization of I-Mab Biopharma (IMAB)
Market cap: $0.97 Billion
As of July 2022 I-Mab Biopharma has a market cap of $0.97 Billion. This makes I-Mab Biopharma the world's 4360th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of I-Mab Biopharma from 2020 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.97 B | -74.23% |
| 2021 | $3.78 B | 12.05% |
| 2020 | $3.38 B |
End of Day market cap according to different sources
On Jul 6th, 2022 the market cap of I-Mab Biopharma was reported to be:
$0.91 Billion
$0.96 Billion
$0.96 Billion
$0.96 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $1.91 B | 96.68% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $0.02 B | -97.11% | 🇺🇸 USA |